about
Stearic acid-rich interesterified fat and trans-rich fat raise the LDL/HDL ratio and plasma glucose relative to palm olein in humansA Nested Case-Control Study of Metabolically Defined Body Size Phenotypes and Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)Interactions between plasma levels of 25-hydroxyvitamin D, insulin-like growth factor (IGF)-1 and C-peptide with risk of colorectal cancerAssociation of C-peptide and leptin with prostate cancer incidence in the Health Professionals Follow-up Study.Dietary insulin index and insulin load in relation to endometrial cancer risk in the Nurses' Health Study.Association between C-peptide concentration and prostate cancer incidence in the CLUE II cohort study.Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women.A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer.Effects of panax quinquefolium on streptozotocin-induced diabetic rats: role of C-peptide, nitric oxide and oxidative stress.Aspirin use, body mass index, physical activity, plasma C-peptide, and colon cancer risk in US health professionals.Effect of Short Term CPAP Therapy in Obstructive Sleep Apnea Patients with Metabolic SyndromeAnalysis of insulin in human breast milk in mothers with type 1 and type 2 diabetes mellitusMagnesium intake, plasma C-peptide, and colorectal cancer incidence in US women: a 28-year follow-up study.Influence of Fasting Status and Sample Preparation on Metabolic Biomarker Measurements in Postmenopausal Women.Relating Phthalate and BPA Exposure to Metabolism in Peripubescence: The Role of Exposure Timing, Sex, and Puberty.IMMULITE 2000 age and sex-specific reference intervals for alpha fetoprotein, homocysteine, insulin, insulin-like growth factor-1, insulin-like growth factor binding protein-3, C-peptide, immunoglobulin E and intact parathyroid hormoneSerum Ceramide Kinase as a Biomarker of Cognitive Functions, and the Effect of Using Two Slimming Dietary Therapies in Obese Middle Aged Females.Sleep Deficiency is a Modifiable Risk Factor for Obesity and Cognitive Impairment and Associated with Elevated Visfatin.Association between markers of glucose metabolism and risk of colorectal cancer.Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women.Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer.Plasma C-peptide is inversely associated with calcium intake in women and with plasma 25-hydroxy vitamin D in men.The Frequency of Type 2 Diabetes Mellitus among Diabetic Children in El Minia Governorate, EgyptObesity-related markers and breast cancer in CPS-II Nutrition Cohort.Longitudinal associations of blood markers of insulin and glucose metabolism and cancer mortality in the third National Health and Nutrition Examination Survey.Obesity related hyperinsulinaemia and hyperglycaemia and cancer development.Comparison of consumption behavior and appetite sensations among patients with type 2 diabetes mellitus after bariatric surgery.When to worry about hypoglycemia.Diabetes and cancer relationships.Serum C-peptide, Total and High Molecular Weight Adiponectin, and Pancreatic Cancer: Do Associations Differ by Smoking?Development and validation of empirical indices to assess the insulinaemic potential of diet and lifestyle.Associations between adherence to the World Cancer Research Fund/American Institute for Cancer Research cancer prevention recommendations and biomarkers of inflammation, hormonal, and insulin response.Omega-3 fatty acid supplementation combined with acute aerobic exercise does not alter the improved post-exercise insulin response in normoglycemic, inactive and overweight men.Metabolomic Determinants of Metabolic Risk in Mexican Adolescents.Effect of nicardipine treatment on carbohydrate and lipoprotein metabolism in patients with hypertension.HDL subfractions and adipose tissue metabolism in the reduced-obese state.Six methods for the determination of C-peptide evaluated.
P2860
Q21245068-111312EE-87AE-4E04-9958-398A4C1115C0Q28601163-EBC16BC5-2D67-45A4-A401-92B7900803BCQ28740805-D4B13904-CC8D-4ADF-BBE5-3CA6CCE4A32DQ33640049-C3019EB7-0914-44D7-8EA0-35085B016BA0Q33992510-8F97BED9-A228-4700-8488-7F0D404EAFA6Q34203868-AC03125D-A4C0-43B6-86B1-DBA94E57D1B0Q34478629-A8912371-33A3-4F17-87B1-0F79414BFA45Q34954039-7EBBBEBA-03C0-4EF2-B71F-45079EC73A66Q35046125-20C985D2-4978-437E-ADC9-A7C12B12FCFBQ35450708-D8D733DA-3001-4B0F-A8C2-2D06F66FC111Q35622660-77226E22-70E0-4FCB-B8B8-C77A58CEB00CQ35829799-487659CA-8FA5-46D9-86D9-BB11EBDF35B1Q35859025-D1E774B2-1872-4750-BB46-45E5847854CFQ36216087-44445502-960D-4FFF-8248-52B572EE15C3Q36431649-BE252855-D73C-467E-95A6-87DAA288B1F7Q36797171-04AA6291-534F-4063-911F-887A851E663AQ36929074-A5C62CCF-FF8B-413C-A962-4342696EDBB3Q36929374-E41495F7-2464-4941-8C36-6E7D28733044Q37063516-DA60EF9E-8859-486B-A23F-704F16921422Q37090766-CAEC4A41-F851-46CB-9788-68BC3B5EF661Q37103052-83C0A309-3482-4649-B0AD-2D296ECB6420Q37105809-8C71D1EB-F58D-447E-80B3-6F2486C16069Q37109587-A3AAAA10-A8D6-4DAE-844E-C3D2DC8300A8Q37172377-7FF28BD8-A359-435F-BA2A-476812868AA4Q37279091-BED1C60F-8C4F-4F88-9C21-BB31FE97B7B0Q37503147-AF121E48-5DD6-4576-89AE-D4D6B8DBEF6AQ37717858-C3FC9FDC-CCFC-43C5-AE63-1A0A64785CBBQ37939930-C36BFAD9-C6D1-42D6-9EB2-411A4AF0F5B1Q38097984-D6ACAD11-6494-4ECA-AF11-EFC29EF3F4E6Q38769343-F1616F90-86F8-4090-B2B9-D8021AAA40ACQ39208004-5847E56C-22DC-4215-9E0A-DB5781761CB8Q39230400-C8E6CBEB-6EAC-4D2A-99E3-D33DE52E7DDEQ39786117-DBA78DC2-D969-49C0-99A3-F1746DAB61A7Q40101741-4C965987-A3E2-43A3-BECC-1275DDB05E07Q42558423-857E4056-1E14-4B42-9C86-7FB331EDD6CFQ51620831-BAE82885-6891-4980-BF40-95BCADF106A3Q52915852-2C46BB87-346D-4E9F-B47F-5ED46E077449
P2860
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
C-peptide measurement: methods and clinical utility.
@en
type
label
C-peptide measurement: methods and clinical utility.
@en
prefLabel
C-peptide measurement: methods and clinical utility.
@en
P2860
P1476
C-peptide measurement: methods and clinical utility.
@en
P2093
Garcia-Webb P
P2860
P304
P356
10.3109/10408368409165766
P577
1984-01-01T00:00:00Z